Write in a clean editor, then format for Therapeutic Advances in Chronic Disease in one click — DocuGuru applies the official SAGE template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Therapeutic Advances in Chronic Disease is a peer-reviewed journal published by SAGE, covering Liver Disease Diagnosis and Treatment, Diabetes, Cardiovascular Risks, and Lipoproteins, Rheumatoid Arthritis Research and Therapies.
| Publisher | SAGE |
|---|---|
| Reference style | Author–year (Harvard) Author–year — (Smith, 2023) in the text Smith, A., Jones, B. and Lee, C. (2023) 'A representative article title', Therapeutic Advances in Chronic Disease, 12(3), pp. 45–58.
Formats any DOI in Therapeutic Advances in Chronic Disease style. No sign-up. |
| Publishes research in | Liver Disease Diagnosis and Treatment Diabetes, Cardiovascular Risks, and Lipoproteins Rheumatoid Arthritis Research and Therapies Psoriasis: Treatment and Pathogenesis Asthma and respiratory diseases |
| ISSN | 2040-6223 |
| Citation impact (2-yr) | 3.37 |
| h-index | 68 |
| i10-index | 433 |
| Total citations | 20,427 |
| Article processing charge | $2,300 |
| Open access | Yes |
| Top institutions publishing here | Chinese Academy of Medical Sciences & Peking Union Medical College |
| Journal website | us.sagepub.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Obstructive sleep apnoea (OSA) is a common disorder characterized by repetitive episodes of nocturnal breathing cessation due to upper airway collapse. OSA causes severe symptoms, such as excessive daytime somnolence, and is associated with a significant cardiovascular morbidity and mortality. Different treatment options are now available for an effective management of this disease. After more…
The chronic lung diseases, asthma and chronic obstructive pulmonary disease (COPD), are common affecting over 500 million people worldwide and causing substantial morbidity and mortality. Asthma is typically associated with Th2-mediated eosinophilic airway inflammation, in contrast to neutrophilic inflammation observed commonly in COPD. However, there is increasing evidence that the eosinophil might play an important…
Sarcoidosis is a granulomatous inflammatory disease with unknown etiology. Epidemiological studies have contributed greatly to our knowledge about sarcoidosis, providing critical information on the determinants and distribution of the disease. In this review, we summarize recently published findings from epidemiological studies on sarcoidosis. We review the epidemiological tools used, the incidence and prevalence of disease,…
Early onset type 2 diabetes mellitus (T2DM) is increasingly prevalent with a significant impact on the individual, healthcare service delivery and planning. The individuals are likely to be obese, lead a sedentary lifestyle, have a strong family history of T2DM, be of black and minority ethnic (BME) origin and come from a less affluent socioeconomic…
Growing evidence suggests that polyphenols could be serious candidates to explain the protective effects of plant-derived foods and beverages. Based on current studies, a general consensus has been achieved to sustain the hypothesis that the specific intake of foods and beverages containing relatively high concentrations of flavonoids may play a meaningful role in reducing cardiovascular…
